Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$637M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$506M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$438M |
| 4 |
State Street SPDR S&P Retail ETF
XRT
|
+$277M |
| 5 |
Comcast
CMCSA
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CPN
Calpine Corporation
CPN
|
+$298M |
| 2 |
Gilead Sciences
GILD
|
+$235M |
| 3 |
CVA
Covanta Holding Corporation
CVA
|
+$188M |
| 4 |
Apple
AAPL
|
+$180M |
| 5 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 4.89% |
| 2 | Energy | 4.68% |
| 3 | Technology | 4.17% |
| 4 | Communication Services | 3.74% |
| 5 | Financials | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6626
First Trust S&P REIT Index Fund
FRI
$189M
| $11K | ﹤0.01% |
540
| – | – |
|
6627
Foster
FSTR
$430M
| $11K | ﹤0.01% |
199
-303
| -60% | -$15.1K |
|
6628
Green Dot
GDOT
$743M
| $11K | ﹤0.01% |
614
-441
| -42% | -$8.14K |
|
6629
Gorman-Rupp
GRC
$2.14B
| $11K | ﹤0.01% |
334
-410
| -55% | -$13.3K |
|
6630
Heron Therapeutics
HRTX
$93.9M
| $11K | ﹤0.01% |
+925
| New | +$11.1K |
|
6631
Haverty Furniture Companies
HVT
$397M
| $11K | ﹤0.01% |
442
-378
| -46% | -$9.6K |
|
6632
Karyopharm Therapeutics
KPTI
$43.5M
| $11K | ﹤0.01% |
16
-4
| -20% | -$1.86K |
|
6633
Medifast
MED
$109M
| $11K | ﹤0.01% |
327
-3,110
| -90% | -$96.9K |
|
6634
Merit Medical Systems
MMSI
$5.07B
| $11K | ﹤0.01% |
756
-983
| -57% | -$13.6K |
|
6635
Natural Gas Services Group
NGS
$472M
| $11K | ﹤0.01% |
305
-1,518
| -83% | -$47.1K |
|
6636
NMI Holdings
NMIH
$3.37B
| $11K | ﹤0.01% |
+1,109
| New | +$12.2K |
|
|
PDS
6637
PUT
Precision Drilling
PDS
$999M
| $11K | ﹤0.01% |
40
-125
| -76% | -$32.2K |
|
6638
QuidelOrtho
QDEL
$1.14B
| $11K | ﹤0.01% |
507
-1,105
| -69% | -$25.4K |
|
6639
Qualys
QLYS
$5.1B
| $11K | ﹤0.01% |
414
-1,475
| -78% | -$33.5K |
|
6640
REX American Resources
REX
$1.42B
| $11K | ﹤0.01% |
816
-36,540
| -98% | -$402K |
|
6641
Stock Yards Bancorp
SYBT
$2.64B
| $11K | ﹤0.01% |
555
-306
| -36% | -$5.96K |
|
|
TRST
6642
Trustco Bank Corp NY
TRST
$970M
| $11K | ﹤0.01% |
370
-402
| -52% | -$13.4K |
|
6643
World Acceptance Corp
WRLD
$834M
| $11K | ﹤0.01% |
152
-518
| -77% | -$40.3K |
|
|
CHUY
6644
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $11K | ﹤0.01% |
291
-369
| -56% | -$13K |
|
|
HSTO
6645
DELISTED
Histogen Inc. Common Stock
HSTO
| $11K | ﹤0.01% |
6
+5
| +500% | +$6.68K |
|
|
XLRN
6646
DELISTED
Acceleron Pharma
XLRN
| $11K | ﹤0.01% |
341
+102
| +43% | +$3.41K |
|
|
FLXN
6647
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $11K | ﹤0.01% |
822
-1,101
| -57% | -$15K |
|
|
CEL
6648
DELISTED
Cellcom Israel, Ltd.
CEL
| $11K | ﹤0.01% |
950
| – | – |
|
|
I
6649
DELISTED
INTELSAT S. A.
I
| $11K | ﹤0.01% |
610
-213,946
| -100% | -$3.97M |
|
|
EMCI
6650
DELISTED
EMC INS Group Inc
EMCI
| $11K | ﹤0.01% |
563
+290
| +106% | +$6.33K |
|
Similar funds
Barclays's Q2 2014 Portfolio in Review
As of Q2 2014, Barclays held 8,150 positions worth $94.6B, up 7.1% from $88.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays's Q2 2014 filing shows 480 new, 3,032 increased, 3,756 reduced and 467 closed positions. Its largest new stake was Blackstone Mortgage Trust: 1,000,000 shares worth $29M. The largest sale was Calpine Corporation, an estimated $298M.
By sector, the portfolio is most concentrated in Healthcare at 4.9% of assets, down from 5.8% a quarter earlier, followed by Energy and Technology.
- Barclays's largest Q2 2014 buy was Blackstone Mortgage Trust: 1,000,000 shares worth $29M.
- Barclays added most to Phillips 66 in Q2 2014, an estimated $637M increase.
- Barclays's biggest Q2 2014 reduction was Calpine Corporation, cutting an estimated $298M.
- Barclays fully exited BRE PROPERTIES INC CL A in Q2 2014, selling an estimated $91.7M.
- Barclays's ten largest holdings make up 26% of its $94.6B portfolio in Q2 2014.
- Barclays opened 480 new positions and closed 467 in Q2 2014.
- Barclays's portfolio value rose 7.1% quarter-over-quarter to $94.6B.
Based on Barclays's 13F filing for Q2 2014, filed 14 Aug 2014.